There has been increasing focus on the rising burden of atrial fibrillation (AF) since the turn
of the millennium. The AF epidemic is projected not only to have an impact on morbidity and …

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, affecting 1% to 2% of the
general population. It is characterized by rapid and disorganized atrial activation leading to …

Atrial fibrillation (AF) is an extremely common clinical problem associated with increased
morbidity and mortality. Current antiarrhythmic options include pharmacological, ablation …

Atrial fibrillation (AF) is the most prevalent sustained arrhythmia found in clinical practice. AF
rarely exists as a single entity but rather as part of a diverse clinical spectrum of …

Around the world there are 33.5 million patients suffering from atrial fibrillation (AF) with an
annual increase of 5 million cases. Most AF patients have an established form of an atrial …

Current evidence suggests that the pathogenesis of atrial fibrillation (AF) is multifactorial.
The observation that AF, once present, alters the electrophysiologic properties of the atrial …

With a substantial impact on morbidity and mortality, the growing “epidemic” of atrial
fibrillation (AF) intersects with a number of conditions, including aging, thromboembolism …

Atrial fibrillation (AF) and heart failure (HF) are both highly prevalent diseases and are
accompanied by a significant disease burden and increased mortality. Although the …

Atrial fibrillation (AF) is the most common clinically significant arrhythmia, and it increases
stroke risk. A preventive approach to AF is needed because virtually all treatments such as …

Background Inflammation markers have been associated with cardiovascular diseases
including atrial fibrillation. This arrhythmia is the most frequent, with an incidence of 38/1000 …